Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 9—September 2022
Research

Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016

Jonathon R. Campbell, Placide Nsengiyumva, Leslie Y. Chiang, Frances Jamieson, Hadeel Khadawardi, Henry K.-H. Mah, Olivia Oxlade, Hayden Rasberry, Elizabeth Rea, Kamila Romanowski, Natasha F. Sabur, Beate Sander, Aashna Uppal, James C. Johnston, Kevin SchwartzmanComments to Author , and Sarah K. Brode
Author affiliations: McGill University, Montreal, Quebec, Canada (J.R. Campbell, P. Nsengiyumva, O. Oxlade, A. Uppal, K. Schwartzman); Research Institute of the McGill University Health Centre, Montreal (J.R. Campbell, P. Nsengiyumva, H. Rasberry, A. Uppal, K. Schwartzman); McGill International TB Centre, Montreal (J.R. Campbell, O. Oxlade, K. Schwartzman); British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada (L.Y. Chiang, K. Romanowski, J.C. Johnston); University of Toronto, Toronto, Ontario, Canada (F. Jamieson, E. Rea, B. Sander, S.K. Brode); Public Health Ontario, Toronto (F. Jamieson, B. Sander); West Park Healthcare Centre, Toronto (H. Khadawardi, H.K.-H. Mah, N.F. Sabur, S.K. Brode); Toronto Public Health, Toronto (E. Rea); University of British Columbia, Vancouver (K. Romanowski, J.C. Johnston); St. Michael’s Hospital, Toronto (N.F. Sabur); University Health Network, Toronto (B. Sander, S.K. Brode); Montreal Chest Institute, Montreal (K. Schwartzman)

Main Article

Table 2

Total costs and component costs of managing different forms of TB at 3 treatment centers, Canada, July 2010–June 2016*

Characteristic Cost, in 2020 Canadian dollars
TB infection, n = 90 DS TB, n = 90 INHR TB, n = 71 MDR TB, n = 62
Median (IQR) costs†
Total costs 804 (587–1,205) 12,148 (4,388–24,842) 19,319 (7,117–41,318) 119,014 (80,642–164,015)
Diagnosis 267 (217–376) 701 (526–1,026) 819 (657–1,049) 1,083 (925–1,331)
Treatment 521 (377–771) 2,145 (1,614–3,187) 2,864 (2,263–3,919) 61,426 (29,840–108,703)
Posttreatment monitoring 0 (0–0) 139 (28–283) 130 (39–195) 193 (39–341)
Hospitalization 0 (0–0) 2,600 (0–15,524) 10,400 (0–27,227) 41,216 (35,178–55,766)
Associated with public health interventions
 0 (0–0)
 3,174 (632–5,232)
 2,885 (1,111–6,174)
 6,399 (4,657–6,798)
Mean costs‡
Total costs 917 15,772 32,343 131,780
Diagnosis 308 789 860 1,233
Treatment 587 2,585 4,641 74,709
Posttreatment monitoring 22 181 166 243
Hospitalization 0 8,587 19,963 48,791
Associated with public health interventions 0 3,630 6,713 6,804

*AFB, acid-fast bacilli; DS, drug-susceptible; INHR, isoniazid-resistant; IQR, interquartile range; MDR, multidrug-resistant; TB, tuberculosis. †Component values may not sum to the total cost value because of use of medians. ‡Component values may not sum to the total cost value because of rounding.

Main Article

Page created: July 05, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external